Japanese firm acquires Israeli pharmaceutical company for $1.1B

Neuroderm, the Israeli pharmaceutical company that deals with “next-generation treatments” was just bought for $1.1B in cash by Mitsubishi Tanabe Pharma

By i24NEWS


Israeli pharmaceutical company Neuroderm has been bought out in a massive deal for $1.1 billion by Japan’s Mitsubishi Tanabe Pharma Corp, the company announced on Monday.

The all-cash deal will expand the company’s business overseas, according to Reuters.

Medical student conducting research – Photo: Tel Aviv University’s Sackler School of Medicine

NeuroDerm develops drugs and medical devices for central nervous system (CNS) disorders such as Parkinson’s, in which it was the first to develop a key treatment currently used for the disease.

According to the company’s website, they are a clinical-stage pharmaceutical company developing “next-generation treatments.”


View original i24NEWS publication at: